These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16958621)

  • 1. Fatty liver is an integral feature of familial combined hyperlipidaemia: relationship with fat distribution and plasma lipids.
    Brouwers MC; Bilderbeek-Beckers MA; Georgieva AM; van der Kallen CJ; van Greevenbroek MM; de Bruin TW
    Clin Sci (Lond); 2007 Jan; 112(2):123-30. PubMed ID: 16958621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-year follow-up of waist circumference, insulin and ALT levels in familial combined hyperlipidaemia.
    Brouwers MC; van Greevenbroek MM; Vermeulen VM; van Lin JM; van der Kallen CJ; de Bruin TW
    Clin Sci (Lond); 2007 Nov; 113(9):375-81. PubMed ID: 17564583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased arterial stiffness in familial combined hyperlipidemia.
    Brouwers MC; Reesink KD; van Greevenbroek MM; Meinders JM; van der Kallen CJ; Schaper N; Hoeks AP; Stehouwer CD
    J Hypertens; 2009 May; 27(5):1009-16. PubMed ID: 19402225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty liver--based identification of two distinct hypertriglyceridemic subgroups in familial combined hyperlipidemia.
    Brouwers MC; van Greevenbroek MM; Bilderbeek-Beckers MA; Robertus-Teunissen MG; van der Kallen CJ; Stehouwer CD; de Bruin TW
    Metabolism; 2007 Oct; 56(10):1311-7. PubMed ID: 17884438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abdominal obesity and expression of familial combined hyperlipidemia.
    van der Kallen CJ; Voors-Pette C; de Bruin TW
    Obes Res; 2004 Dec; 12(12):2054-61. PubMed ID: 15687407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension.
    Hunt SC; Wu LL; Hopkins PN; Stults BM; Kuida H; Ramirez ME; Lalouel JM; Williams RR
    Arteriosclerosis; 1989; 9(3):335-44. PubMed ID: 2497719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma proprotein convertase subtilisin kexin type 9 is a heritable trait of familial combined hyperlipidaemia.
    Brouwers MC; van Greevenbroek MM; Troutt JS; Bonner Freeman A; Lu A; Schaper NC; Konrad RJ; Stehouwer CD
    Clin Sci (Lond); 2011 Nov; 121(9):397-403. PubMed ID: 21539517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of insulin sensitivity and ApoB levels to intra-abdominal fat in subjects with familial combined hyperlipidemia.
    Purnell JQ; Kahn SE; Schwartz RS; Brunzell JD
    Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):567-72. PubMed ID: 11304474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia.
    Venkatesan S; Cullen P; Pacy P; Halliday D; Scott J
    Arterioscler Thromb; 1993 Jul; 13(7):1110-8. PubMed ID: 8318511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of intraperitoneal and posterior subcutaneous abdominal adipose tissue compartments as predictors of VLDL apolipoprotein B-100 kinetics in overweight/obese men.
    Chan DC; Watts GF; Barrett PH
    Diabetes Obes Metab; 2003 May; 5(3):202-6. PubMed ID: 12681028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased intima-media thickness in familial combined hyperlipidemia associated with apolipoprotein B.
    Keulen ET; Kruijshoop M; Schaper NC; Hoeks AP; de Bruin TW
    Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):283-8. PubMed ID: 11834529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visceral adipose tissue area is an independent risk factor for hepatic steatosis.
    Park BJ; Kim YJ; Kim DH; Kim W; Jung YJ; Yoon JH; Kim CY; Cho YM; Kim SH; Lee KB; Jang JJ; Lee HS
    J Gastroenterol Hepatol; 2008 Jun; 23(6):900-7. PubMed ID: 17995942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasonographic and biochemical evaluation of visceral obesity in obese women with non-alcoholic fatty liver disease.
    Fenkci S; Rota S; Sabir N; Akdag B
    Eur J Med Res; 2007 Feb; 12(2):68-73. PubMed ID: 17369120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parabolic relationship between plasma triacylglycerols and LDL-cholesterol in familial combined hyperlipidaemia: the multiple-type hyperlipidaemia explained?
    Brouwers MC; de Graaf J; van Greevenbroek MM; Georgieva AM; van der Kallen CJ; Ter Avest E; Stehouwer CD; Stalenhoef AF; de Bruin TW
    Clin Sci (Lond); 2008 Mar; 114(5):393-401. PubMed ID: 17953518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PNPLA3 gene-by-visceral adipose tissue volume interaction and the pathogenesis of fatty liver disease: the NHLBI family heart study.
    Graff M; North KE; Franceschini N; Reiner AP; Feitosa M; Carr JJ; Gordon-Larsen P; Wojczynski MK; Borecki IB
    Int J Obes (Lond); 2013 Mar; 37(3):432-8. PubMed ID: 22546774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of VLDL composition and apo B-containing particles in familial combined hyperlipidemia.
    Cruz-Bautista I; Mehta R; Cabiedes J; García-Ulloa C; Guillen-Pineda LE; Almeda-Valdés P; Cuevas-Ramos D; Aguilar-Salinas CA
    Clin Chim Acta; 2015 Jan; 438():160-5. PubMed ID: 25172037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aging and obesity on the expression of dyslipidaemia in children from families with familial combined hyperlipidaemia.
    ter Avest E; Sniderman AD; Bredie SJ; Wiegman A; Stalenhoef AF; de Graaf J
    Clin Sci (Lond); 2007 Jan; 112(2):131-9. PubMed ID: 17054424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of type 2 diabetes in familial combined hyperlipidemia.
    Brouwers MCGJ; de Graaf J; Simons N; Meex S; Ten Doeschate S; van Heertum S; Heidemann B; Luijten J; de Boer D; Schaper N; Stehouwer CDA; van Greevenbroek MMJ
    BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32193201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial dyslipidemic hypertension syndrome: familial combined hyperlipidemia, and the role of abdominal fat mass.
    Keulen ET; Voors-Pette C; de Bruin TW
    Am J Hypertens; 2001 Apr; 14(4 Pt 1):357-63. PubMed ID: 11336182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of the lipoprotein structure in the St. Thomas' Mixed Hyperlipidaemic (SMHL) rabbit.
    de Roos B; Caslake MJ; Milliner K; Benson GM; Suckling KE; Packard CJ
    Atherosclerosis; 2005 Jul; 181(1):63-8. PubMed ID: 15939055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.